Market Making agreement with Norne Securities

Report this content

NattoPharma ASA has entered into a market making agreement with Norne Securities with effect from 25 September 2019. The purpose of the agreement is to increase the liquidity of the shares of the company, which are listed on Oslo Stock Exchange. The agreement is in accordance with the standard requirements of Oslo Stock Exchange.

For more information, please contact:

Kjetil Ramsøy

CEO NattoPharma

Email : 

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.


Documents & Links